Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
451817
Reference Type
Journal Article
Title
The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils
Author(s)
Basta, NT; Foster, JN; Dayton, EA; Rodriguez, RR; Casteel, SW
Year
2007
Is Peer Reviewed?
1
Journal
Journal of Environmental Science and Health, Part A: Toxic/Hazardous Substances & Environmental Engineering
ISSN:
1093-4529
EISSN:
1532-4117
Volume
42
Issue
9
Page Numbers
1275-1281
Language
English
PMID
17654147
DOI
10.1080/10934520701434927
Web of Science Id
WOS:000248236700009
Abstract
In vitro gastrointestinal (IVG) methods have been developed to provide an expedient and inexpensive means to estimate bioavailability of arsenic and other contaminants from ingestion of contaminated soil. Both in vivo and in vitro techniques have used a fasting model when determining Pb bioavailability/bioaccessibility as a conservative estimate of risk. Some IVG procedures have incorporated a dosing vehicle (DV) or food (i.e., milk) to simulate in vivo conditions. Potential differences in the bioaccessibility of contaminants between fasting and fed states remain a concern for those interested in adopting in vitro procedures for regulatory purposes. In this study, the effect of eliminating a dough-like DV on As bioaccessibility (BA), and this effect on the relationship between in vitro bioaccessible and in vivo relative bioavailability (RBA) As is determined. Also, the effect of phosphate from the DV on IVG BA is investigated. Two types of smelter-contaminated soils, calcine and iron slag, were used to examine the effect of dosing vehicle (DV) on BA determined by IVG. Dosing vehicle did not affect BA in the gastric extraction (GE) or intestinal extraction (IE) for 3 of the 5 calcinated contaminated soils. Inclusion of DV in the GE slightly increased BA for 2 of the 5 slag-contaminated soils. Increases in BA from DV may be attributed to ligand exchange of arsenate with phosphate. Strong relationships between BA and in vivo RBA As were found with or without DV. Bioaccessible As measured by the GE was strongly correlated with in vivo RBA As ( IVG without DV: r = 0.92, P < 0.01; IVG with DV: r = 0.96; P < 0.01). Similarly, BA measured by the IE was strongly correlated with in vivo RBA As ( IVG without DV: r = 0.90, P < 0.01; IVG with DV: r = 0.96, P < 0.01). The IVG method, with or without DV, is a reliable method to use as a rapid screening tool to provide an estimate of BA in contaminated soils. Further studies should be conducted to determine the influence of foodstuffs on BA for different types of As contaminated soil (i.e., non-smelter soil).
Keywords
contaminated soil; arsenic; bioavailability; risk assessment; exposure; soil ingestion; vitro gastrointestinal method; in-vitro; risk-assessment; solid media; bioavailability; mobility; children; cadmium; lead
Tags
IRIS
•
Arsenic (Inorganic)
1. Literature
PubMed
Toxline, TSCATS, & DART
•
Inorganic Arsenic (7440-38-2) [Final 2025]
1. Initial Lit Search
PubMed
ToxNet
4. Considered through Oct 2015
6. Cluster Filter through Oct 2015
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity